Showing results (91-100 of 768) with videos related to
Sort By:
Pageof 77
Journal of the American Academy of Dermatology|November 25, 2010
The use of cyclosporine in dermatology: part IKarrie T Amor, Caitriona Ryan, Alan MenterJournal of Drugs in Dermatology : JDD|June 20, 2008
Psoriasis and the metabolic syndromeAlice B Gottlieb, Frank Dann, Alan MenterJournal of Drugs in Dermatology : JDD|August 13, 2015
Tumor Necrosis Factor-α Inhibitor Use in Psoriasis Patients With a First-degree Relative With Multiple SclerosisBobbak Mansouri, Mary E Horner, Alan MenterJournal of the American Academy of Dermatology|November 25, 2010
The use of cyclosporine in dermatology: part IICaitriona Ryan, Karrie T Amor, Alan MenterMolecular Diagnosis & Therapy|April 3, 2010
The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasisCaitriona Ryan, Alan Menter, Richard B WarrenJournal of Drugs in Dermatology : JDD|April 3, 2008
Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomesLeon Kircik, Jerry Bagel, Neil Korman, et al.Cutis|July 28, 2006
Impaired skin barrier function in dermatologic disease and repair with moisturizationMark Lebwohl, Lisa G HerrmannJournal of Drugs in Dermatology : JDD|July 10, 2003
Treatment of mycosis fungoides with oral bexarotene combined with PUVADana Kaslow Stern, Mark LebwohlDermatologic Clinics|April 14, 2007
Potential complications associated with the use of biologic agents for psoriasisJoshua A Zeichner, Mark LebwohlPageof 77